Letters
Covid-19: administration of end-of-life drugs
Administration of end-of-life drugs by family caregivers during covid-19: opportunity for future home prescribing plans
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2408 (Published 17 June 2020) Cite this as: BMJ 2020;369:m2408
- Miguel Julião, professor
- Equipa Comunitária de Suporte em Cuidados Paliativos de Sintra, 2635-364 Rio de Mouro, Sintra, Portugal
- migueljuliao{at}gmail.com
Bowers and colleagues’ editorial on the administration of end-of-life drugs by family caregivers during the covid-19 pandemic highlights two things.1 The first is the lack of an evidence base and the second the effect of different cultures and healthcare systems on prescribing essential drugs for home use.
The standard practice of our home based palliative care teams is to prescribe anticipatory drugs …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.